Angela Brueggemann

Angela Brueggemann’s research is focused on understanding bacterial population structure and how changes in that population structure impact on global health and vaccine initiatives. Her research group uses genome sequencing and large collections of bacteria to understand molecular epidemiology and bacterial evolution, especially evolutionary changes related to vaccine selective pressures and antimicrobial resistance. 

Angela has a Wellcome Trust Investigator Award to investigate bacteriocins, which are antimicrobial peptides produced by many bacterial species in order to kill other bacteria. Other major research projects relate to bacteriophages, the impact of pneumococcal vaccination, the burden of meningitis in Africa, and making bacterial genome sequence data widely accessible to the international community. She is also involved in outreach activities for school children and is keen to inspire the next generation of scientists. 

Angela received her DPhil from the University of Oxford in 2004 and was a Senior Research Fellow in the Department of Public Health and Primary Care from 2001-2005.  She was then an Infectious Diseases Lecturer in the Department of Zoology for three years. She was awarded a Wellcome Trust Research Fellowship in 2008 and moved to the Nuffield Department of Medicine in 2013. She moved from Oxford to Imperial College London in 2016 and became a Professor of Infectious Disease Epidemiology in the Department of Medicine. She moved back to Oxford and took up her new post in the Nuffield Department of Population Health in 2019.